Senior insider sale
Chief Executive Officer at LEGEND BIOTECH CORP — senior position signals high conviction
$1.19M
34.54K shares
What this filing means
HUANG YING plans to sell 34.54K shares of LEGEND BIOTECH CORP valued at approximately $1.19M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/25/2025ACC: 0001959173-25-004285
DirectorOfficer· Chief Executive Officer
Since Mar 2026
34.54K
Shares to sell
$1.19M
Approx. market value
12.12K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
6/20/2025
12.12KTotal acquired12.12K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/20/2025 | Restricted Stock Vesting Compensation | 12.12K | — |
| Total | 12.12K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
11.81K
Market value
$408.6K
6/24/2025
—Completed
Units to sell
6.55K
Market value
$226.2K
5/1/2025
—Completed
Units to sell
4.06K
Market value
$143.4K
3/25/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
12.12K
Market value
$408.7K
6/25/2025
Total
Units
34.54K
Value
$1.19M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/24/2025 | 11.81K | $408.6K | — | Completed |
5/1/2025 | 6.55K | $226.2K | — | Completed |
3/25/2025 | 4.06K | $143.4K | — | Completed |
| Planned — Approximate Date | ||||
6/25/2025 | 12.12K | $408.7K | NASDAQ | Planned |
| Total | 34.54K | $1.19M | ||